CARISOPRODOL, ASPIRIN AND CODEINE PHOSPHATE Drug Patent Profile
✉ Email this page to a colleague
When do Carisoprodol, Aspirin And Codeine Phosphate patents expire, and what generic alternatives are available?
Carisoprodol, Aspirin And Codeine Phosphate is a drug marketed by Ingenus Pharms Nj, Oxford Pharms, and Sandoz. and is included in three NDAs.
The generic ingredient in CARISOPRODOL, ASPIRIN AND CODEINE PHOSPHATE is aspirin; carisoprodol; codeine phosphate. There are twenty-two drug master file entries for this compound. Additional details are available on the aspirin; carisoprodol; codeine phosphate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CARISOPRODOL, ASPIRIN AND CODEINE PHOSPHATE?
- What are the global sales for CARISOPRODOL, ASPIRIN AND CODEINE PHOSPHATE?
- What is Average Wholesale Price for CARISOPRODOL, ASPIRIN AND CODEINE PHOSPHATE?
Summary for CARISOPRODOL, ASPIRIN AND CODEINE PHOSPHATE
US Patents: | 0 |
Applicants: | 3 |
NDAs: | 3 |
DailyMed Link: | CARISOPRODOL, ASPIRIN AND CODEINE PHOSPHATE at DailyMed |
US Patents and Regulatory Information for CARISOPRODOL, ASPIRIN AND CODEINE PHOSPHATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ingenus Pharms Nj | CARISOPRODOL, ASPIRIN AND CODEINE PHOSPHATE | aspirin; carisoprodol; codeine phosphate | TABLET;ORAL | 040860-001 | Jan 7, 2010 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Oxford Pharms | CARISOPRODOL, ASPIRIN AND CODEINE PHOSPHATE | aspirin; carisoprodol; codeine phosphate | TABLET;ORAL | 040283-001 | Dec 29, 1998 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Sandoz | CARISOPRODOL, ASPIRIN AND CODEINE PHOSPHATE | aspirin; carisoprodol; codeine phosphate | TABLET;ORAL | 040118-001 | Apr 16, 1996 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |